You are here

Nucana

NuCana's twist on chemo drug Gemzar fails in phase 3 again

Fierce Pharma

Wed, 03/9/22 - 11:17 pm

clinical trials

3 Biotech Stocks That Jumped Last Week

Motley Fool

Sun, 01/17/21 - 04:54 pm

Lexicon Pharmaceuticals

Aldeyra Therapeutics

Futility analysis augurs defeat in pivotal trial testing of NuCana's lead drug in metastatic pancreatic cancer

Endpoints

Wed, 08/21/19 - 09:51 am

clinical trials

metastatic pancreatic cancer

How A Small Scottish Biotech Firm Could Win A Decisive Battle Against Cancer

Forbes

Mon, 10/29/18 - 09:44 am

drug development

ASCO spotlight presaged two more biotech IPOs angling for $215M

Endpoints

Tue, 09/5/17 - 09:35 am